UNH UNITEDHEALTH GROUP INC
Hospital & Medical Service Plans · NYSE · SEC CIK 731766 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $112.69B | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B |
| Cost of revenue | $13.71B | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B |
| SG&A expense | $14.37B | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B |
| Operating income | $6.56B | $7.99B | $8.99B | $380.00M | $4.32B | $5.15B | $9.12B | $7.77B |
| Interest expense | $963.00M | $962.00M | $955.00M | $974.00M | $1.00B | $1.03B | $998.00M | $1.00B |
| Pretax income | $5.52B | $6.97B | $7.96B | -$720.00M | $3.23B | $4.08B | $8.11B | $6.79B |
| Income tax | $1.22B | $1.30B | $1.48B | -$938.00M | $686.00M | $510.00M | $1.63B | $1.01B |
| Net income | $4.11B | $5.48B | $6.28B | $10.00M | $2.35B | $3.41B | $6.29B | $5.54B |
| EBITDA | $7.64B | $9.03B | $10.02B | $1.50B | $5.41B | $6.23B | $10.18B | $8.81B |
| EPS (basic) | 4.58 | 6.06 | 6.92 | — | 2.59 | 3.76 | 6.90 | — |
| EPS (diluted) | 4.56 | 6.04 | 6.90 | — | 2.59 | 3.74 | 6.85 | — |
| Dividends declared per share | 2.32 | 2.32 | 2.21 | 2.21 | 2.21 | 2.21 | 2.10 | 2.10 |
| Weighted avg. shares (diluted) | 902.00M | 906.00M | 910.00M | — | 908.00M | 910.00M | 918.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $25.84B | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B |
| Short-term investments | $2.70B | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B |
| Receivables | $20.54B | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B |
| Inventory | — | — | — | $3.30B | — | — | — | $3.80B |
| Current assets | $85.59B | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B |
| PP&E, net | $10.95B | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B |
| Goodwill | $112.97B | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B |
| Intangibles | $20.38B | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B |
| Total assets | $312.78B | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B |
| Current liabilities | $115.83B | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B |
| Short-term debt | $5.62B | $3.83B | $6.48B | $6.07B | $7.74B | $5.70B | $9.99B | $4.54B |
| Long-term debt | $68.71B | $69.50B | $71.44B | $72.32B | $72.40B | $73.50B | $71.28B | $72.36B |
| Total debt | $74.33B | $73.33B | $77.92B | $78.39B | $80.14B | $79.19B | $81.27B | $76.90B |
| Total liabilities | $207.24B | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B |
| Shareholders' equity | $98.10B | $98.45B | $97.88B | $94.11B | $95.79B | $94.72B | $95.04B | $92.66B |
| Net debt | $48.49B | $44.74B | $49.92B | $54.02B | $52.93B | $50.60B | $50.55B | $51.59B |
| Shares outstanding | 896.00M | 905.00M | 908.00M | 906.00M | 906.00M | 905.00M | 910.00M | 915.00M |
| Cash flow statement | ||||||||
| Operating cash flow | $5.12B | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B |
| Capital expenditure | $859.00M | $799.00M | $763.00M | $948.00M | $890.00M | $886.00M | $898.00M | $912.00M |
| Free cash flow | $4.26B | $10.25B | $8.15B | $160.00M | $5.05B | $6.30B | $4.56B | $1.46B |
| Investing cash flow | -$4.57B | -$1.80B | -$2.45B | -$2.61B | -$4.56B | -$1.44B | -$74.00M | -$1.12B |
| Financing cash flow | -$3.42B | -$8.62B | -$2.99B | -$1.03B | -$2.77B | -$7.95B | $99.00M | -$8.34B |
| Depreciation & amortization | $1.07B | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B |
| Stock-based compensation | $219.00M | $276.00M | $348.00M | $176.00M | $223.00M | $197.00M | $375.00M | $187.00M |
| Dividends paid | $2.08B | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B |
| Share buybacks | $3.38B | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.